1-2 of 2
Keywords: Degarelix
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Degarelix versus Goserelin plus Bicalutamide Therapy for Lower Urinary Tract Symptom Relief, Prostate Volume Reduction and Quality of Life Improvement in Men with Prostate Cancer: A Systematic Review and Meta-Analysis

Available to Purchase
Subject Area:
Further Areas
Yuanshan Cui, Huantao Zong, Huilei Yan, Nan Li, Yong Zhang
Journal: Urologia Internationalis
Urol Int (2014) 93 (2): 152–159.
https://doi.org/10.1159/000356272
Published Online: 01 March 2014
...Yuanshan Cui; Huantao Zong; Huilei Yan; Nan Li; Yong Zhang Objective: We performed a systematic review and meta-analysis to assess the efficacy and tolerability of degarelix for lower urinary tract symptom relief, prostate volume reduction and quality of life improvement in men with prostate cancer...
View article titled, Degarelix versus Goserelin plus Bicalutamide Therapy for Lower Urinary Tract Symptom Relief, Prostate Volume Reduction and Quality of Life Improvement in Men with Prostate Cancer: A Systematic Review and Meta-Analysis
Open the PDF for Degarelix versus Goserelin plus Bicalutamide Therapy for Lower Urinary Tract Symptom Relief, Prostate Volume Reduction and Quality of Life Improvement in Men with Prostate Cancer: A Systematic Review and Meta-Analysis in another window
Journal Articles

Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233)

Available to Purchase
Subject Area:
Further Areas
John Anderson, Ghandi Al-Ali, Manfred Wirth, Joan Benejam Gual, Francisco Gomez Veiga, Enrico Colli, Egbert van der Meulen, Bo-Eric Persson
Journal: Urologia Internationalis
Urol Int (2013) 90 (3): 321–328.
https://doi.org/10.1159/000345423
Published Online: 15 December 2012
...John Anderson; Ghandi Al-Ali; Manfred Wirth; Joan Benejam Gual; Francisco Gomez Veiga; Enrico Colli; Egbert van der Meulen; Bo-Eric Persson Introduction: No studies to date have assessed the efficacy/tolerability of degarelix in the relief of lower urinary tract symptoms (LUTS) secondary...
View article titled, Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233)
Open the PDF for Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233) in another window